An Explorative Prospective Observational Study to Describe Morphokinetic De-selection Parameters in Human Embryos | NCT02018159 | Trialant
CompletedObservationalUpdated Aug 28, 2017
An Explorative Prospective Observational Study to Describe Morphokinetic De-selection Parameters in Human Embryos
ClinicalTrials.gov ID
NCT02018159
Lead Sponsor
Ferring PharmaceuticalsINDUSTRY
Overall Status
Completed
Study Type
Observational
Enrollment
738Actual
Last Update Posted
Aug 28, 2017Actual
Start Date
Jan 2014
Primary Completion Date
Feb 12, 2016Actual
Completion Date
May 12, 2016Actual
Brief Summary
This post-marketing, multi-center prospective study will be conducted in a open-label, non-interventional setting, for women seeking fertility treatment and will describe morphokinetic de-selection parameters in human embryos.
Infertility
menotropin
Ages Eligible for Study
Adult (18-64)
Sexes Eligible for Study
Female
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age 21-45 years
In Vitro Fertilisation/Intra Cytoplasmic Sperm Injection treatment in long or short protocol
Receiving follicle stimulation with Menopur 600/1200 IU
Observational Model
Cohort
Time Perspective
Prospective
No central contacts
There are no central contacts for this study.
Fertilitetsklinikken Hospitalsenheden Horsens, Regionshospitalet Horsens (there may be other sites in this country)